Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site footer’s revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied screen. This indicates the page is not currently accessible to users.SummaryDifference18%

- Check56 days agoChange DetectedAn NIH grant/contract funding note has been added to the page. The page revision has been updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4 to reflect a newer version of the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, reflecting a small system version update.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.